¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutral density filter"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • amorphous density
    ¹«Á¤Çü¹Ðµµ
  • bone density
    »À¹Ðµµ, °ñ¹Ðµµ
  • buoyant density
    ºÎ·Â¹Ðµµ
  • coarse reticulonodular density
    °ÅÄ£±×¹°°áÀýÀ½¿µ
  • density
    ¹Ðµµ, À½¿µ, ³óµµ
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • density difference
    1. ¹ÐµµÂ÷ 2. À½¿µÂ÷
  • density gradient
    ¹Ðµµ±â¿ï±â
  • density gradient centrifugation
    ¹Ðµµ±â¿ï±â¿ø½ÉºÐ¸®
  • density sampling
    ¹ÐµµÇ¥º»ÃßÃâ(¹ý)
  • electron density
    ÀüÀڹеµ
  • echogenic density
    ¸Þ¾Æ¸®¹ß»ý¹Ðµµ
  • energy flux density
    ¿¡³ÊÁö¿òÁ÷Àӹеµ, ¿¡³ÊÁöÀ¯µ¿¹Ðµµ
  • epitope density
    Ç׿ø°áÁ¤ÀÎÀڹеµ
  • equilibrium density gradient centrifugation
    ÆòÇü¹Ðµµ±â¿ï±â¿ø½É¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • asymmetric density
    ºñ´ëĪÀ½¿µ
  • bone density
    »À¹Ðµµ, °ñ¹Ðµµ
  • buoyant density
    ºÎ·Â¹Ðµµ
  • coarse reticulonodular density
    °ÅÄ£±×¹°°áÀýÇüÀ½¿µ
  • confluent peripheral density
    À¶ÇÕ¸»ÃÊÀ½¿µ
  • density gradient centrifugation
    ¹Ðµµ±¸¹è¿ø½ÉºÐ¸®
  • equilibrium density gradient centrifugation
    ÆòÇü¹Ðµµ±¸¹è¿ø½É¹ý
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • density
    ¹Ðµµ, À½¿µ
  • density difference
    À½¿µÂ÷
  • density gradient
    ¹Ðµµ±â¿ï±â
  • density sampling
    ¹ÐµµÇ¥º»ÃßÃâ
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • electron density
    ÀüÀڹеµ
  • energy flux density
    ¿¡³ÊÁö¼Ó¹Ðµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • proton density weighted image
    ¾çÀÚ ¹Ðµµ °­Á¶ ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diatomaceous earth filter
    ±ÔÁ¶Åä ¿©°ú±â
  • double layer filter =dual media f.
    ÀÌÁß¿©°ú±â.
  • dual media filter =double layer f.
    ÀÌÁß¹èÁö¿©°ú±â.
  • field flattening filter
    Á¶»ç¿µ¿ª ÆíÆòÈ­¿©°ú±â
  • filter
    ¿©°ú (¿©°ú±â) (ÕëΦ (ÕëΦÐï))
  • filter
    ÇÊÅÍ
  • filter photometer
    ÇÊÅͱ¤µµ°è
  • filter, Seitz
    ÀÚÀÌÂê ¿©°ú±â
  • filter, membrane
    ¸·Çü ¿©°ú±â
  • filter, sintered glass
    ¼Ò°áÀ¯¸® ¿©°ú±â
  • flattening filter
    ÆíÆòÈ­¿©°ú±â
  • highpass filter
    °íÁÖÆÄÅë°úÇÊÅÍ.
  • interference filter
    °£¼·ÇÊÅÍ
  • low pass filter
    ÀúÅë°ú ¿©°ú±â
  • membrane filter
    ¸·(د)ÇÊÅÍ, ¸·°Å¸£°³.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • discontinuous density gradient
    ºÒ¿¬¼Ó ¹Ðµµ±¸¹è(ÝÕææáÙÚËÓøÎþÛÕ)
  • exponential density gradient
    Áö¼ö ³óµµ ±¸¹è (ò¦â¦ÒØÓøÎøÛÎ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
  • optical density
    Èí±¤µµ(ýåÎÃÓø)
  • sucrose density gradient
    ½´Å©·Î½º ¹Ðµµ ±¸¹è(ÚËÓøÎøÛÎ)
  • superhelix density
    Ãʳª¼± ¹Ðµµ (õ±Õ¢àÁÚËÓø)
  • very high-density lipoprotein
    Ãʰí¹Ðµµ(õ±ÍÔÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-density lipoprotein
    ÃÊÀú¹Ðµµ (õ±î¸ÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
QMF quadrature mirror filter
ULPA ultra low penetration air filter
NPH   1) Neutral Protamine Hagedorn Insulin
    = Isophane Insulin Susp...
ANRL antihypertensive neutral renomedullary lipid
CANP calcium-activated neutral protease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NPH Neutral Protamine Hagedorn
NR Neutral Red
NAA Neutral amino acid
NDF Neutral detergent fiber
NDF Neutral detergent fibre
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • perihilar density
    Æó¹® ÁÖÀ§ À½¿µ
  • photographic density
    »çÁø ÈæÈ­µµ
  • pixel density
    Çȼ¿ À½¿µ, È­¼Ò À½¿µ
  • power density
    Ãâ·Â ¹Ðµµ
    ÀÏÁ¤ Ç¥¸é¿¡ ´ëÇÑ ·¹ÀÌÀú Ãâ·ÂÀÇ ºÐÆ÷ ÃøÁ¤. Ãâ·Â ¹Ðµµ¸¦ À§ÇÑ ´ÜÀ§´Â ÀüÇüÀûÀ¸·Î ÀÏÁ¤ Ç¥¸é ȤÀº ÃÊÁ¡ Å©±â¿¡ ´ëÇÑ 1cm
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighting
    ¾çÀÚ °­Á¶
  • proton spin density
    ¾çÀÚ ¹Ðµµ
  • reticular density
    ¸Á»ó À½¿µ
  • spin density weighted image
    ½ºÇÉ ¹Ðµµ °­Á¶ ¿µ»ó
  • vapo density
    Áõ±â ¹Ðµµ
  • very low density lipoprotein
    ÃÊÀú ºñÁß Áö´Ü¹é, ÃÊÀú ºñÁß ÁöÁú ´Ü¹é, ÃÊÀú ºñÁß Áö´Ü¹éÁú, ÃÊÀú ºñÁß ÁöÁú ´Ü¹éÁú, ÃÊÀúºñÁß Áö¹æ ´Ü¹é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
bird's nest ivc filter <radiology> Introduced 1982; Cook Inc., Bloomington, IN advantages, low profile: 14.5 Fr introducer sheath, low recurrent PE rates (1.1 - 2.7% by clinical history), low IVC thrombosis rates (2.9 - 5.0% by clinical history), placement in large diameter IVCs (not greater than40mm), free-form configuration does not require centreing in IVC disadvantages: stainless steel: ferromagnetic = magnetic susceptibility artifact, more operator dependent, difficult to place in short IVCs (need about 7cm for proper placement), prolapse of filter wires (? clinical significance) see also: indications
(12 Dec 1998)
vena cava filter A filter used for interruption of IVC to prevent pulmonary embolism; e.g., Greenfield filter.
Synonym: venocaval filter.
(05 Mar 2000)
vena-tech ivc filter <radiology> Introduced as LGM (L.G. Medical, France), 1985; FDA aprroval 1991: Vena-Tech, Evanston, IL, 6-leg conical design with 6 stabilizing side bars, biocompatible metal known as Phynox (cobalt,chromium,iron,nickel,moly) Efficacy, recurrent PE: 2-6%, IVC occlusion: 8-24%, migration: 0-12% Advantages, ease of placement, excellent clot trapping efficiency, low profile, lacks ferromagnetic activity: minimal MRI artifacts Disadvantages, incomplete opening (6-19%): decreases clot-trapping efficiency, increased incidence from IJ approach, decreased with rapid deployment, increased IVC thrombosis rates: 8% initial reports; 22-24% on subsequent reports by ultrasound/MRI: 2-19% clinically symptomatic
(12 Dec 1998)
venocaval filter A filter used for interruption of IVC to prevent pulmonary embolism; e.g., Greenfield filter.
Synonym: venocaval filter.
(05 Mar 2000)
Rheinberg filter <equipment> A colour-filter disk to be placed, as a dark field stop would be placed, below the substage condenser.
The central circular area, that is filled with one of the two or three colour filters, should safely subtend the objective aperture. The annular quadrants around this are normally contrasting in colour. This is/are the colour shown by the organisms or other specimen detail against the coloured field. The effect is one kind of optical staining.
(05 Aug 1998)
Greenfield filter A multistrutted spring-styled filter usually placed in the inferior vena cava to prevent venous emboli from reaching the pulmonary circulation from the lower extremity.
(05 Mar 2000)
micropore filter A filter made of a meshwork of cellulose acetate or nitrate and with defined pore size. They can be autoclaved and the smaller pore sizes (0.22m,0.45m) are used for sterilising heat labile materials by filtering out micro organisms. Larger pore size filters are used in setting up Boyden chambers. They are about 150m thick and should be distinguished from Nucleopore filters. Millipore is a trade name for micropore filters.
(18 Nov 1997)
Millipore filter <cell culture, equipment> Trade name for a well known brand of micropore filters.
(12 Jan 1998)
hemming filter <apparatus> A filter placed between two tubes attached to each other, often used with centrifuges to selectively remove a substance of interest from a mixture in one tube and deposit the substance into the other tube.
(09 Oct 1997)
high-pass filter A device or material that allows high frequency signals to pass while attenuating other signals.
(05 Mar 2000)
high quality filter paper Used in paper chromatography.
Synonym: high quality filter paper.
Congo red paper, paper impregnated with Congo red; used as a pH indicator, changing from blue-violet at 3.0 to red at 5.0.
Filter paper, an unsized paper used in pharmacy and chemistry for filtering solutions; many varieties are used for paper chromatography.
(05 Mar 2000)
simon nitinol ivc filter <radiology> Introduced 1990; Nitinol Medical Technologies, Woburn, MA. BARD, thermal memory alloy:titanium and nickel;, straightened form at cool temperatures (4-10C), reforms into predetermined filter shape at body temperatures efficacy, recurrent PE: 0 - 4.8%, IVC thrombosis: 7 - 11% (by clinical symptoms), access site thrombosis: 2 - 10% advantages, narrow introducer sheath (9 Fr), largest choice of access: brachial or left CFV approach without difficulty, only mild MRI artifacts disadvantages, IVC thrombosis: symptomatic occlusion rates higher than reported wtih Greenfield or bird's nest filters, caval penetration: 1 - 33%, caudal drop: exact filter location difficult to predict
(12 Dec 1998)
spatial filter <radiobiology> Device consisting of a lens pair and a pinhole aperture stop. Intensity fluctuations over the spatial extent of a laser beam are removed by passing the focused beam through the aperture stop. The pinhole must be placed in a vacuum to prevent air breakdown by the focused beam. These filters are used to counter the effects caused by self-focusing.
(09 Oct 1997)
nitinol filter A vena cava filter made with a metal that springs into shape when warmed to body heat by the blood after catheter insertion.
(05 Mar 2000)
Nucleopore filter Filter of defined pore size made by etching a polycarbonate filter that has been bombarded by neutrons, the extent of etching determining the pore size. Very thin, with neat circular holes going right through the membrane, not a complex meshwork like micropore filters.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á